Steroidal glucocorticoids are widely prescribed for the treatment of a variety of inflammatory and autoimmune diseases. Although they are effective, the side-effects associated with chronic glucocorticoid treatment, such as osteoporosis and hyperglycemia, can severely limit their long-term use. Hence, there is a need to develop new effective anti-inflammatory agents for systemic use which are dissociated from their unwanted side effects.
No takes yet. Share an insight, caveat, or question.
Hudson et al. (2008) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: